Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Johansen, Nicklas J, Dejgaard, Thomas F, Lund, Asger, Schlüntz, Camilla, Frandsen, Christian S, Forman, Julie L, Wewer Albrechtsen, Nicolai J, Holst, Jens J, Pedersen-Bjergaard, Ulrik, Madsbad, Sten,Journal:
The Lancet Diabetes & Endocrinology
DOI:
10.1016/S2213-8587(20)30030-9
Date:
March, 2020
File:
PDF, 300 KB
2020